loader2
Partner With Us NRI

Company details

3,878.00
3,948.00
3,365.10
5,425.00
6M Return -8.58%
1Y Return -20.00%
Mkt Cap.(Cr) 104,558.95
Volume 4,525
Div Yield 0.77%
OI
-
OI Chg %
-
Volume 4,525

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding

EMA SMA

Delivery and volume

Our Research View

Trading recommendation

Data not found

Investment recommendation

Call Date

24 May 2022

Entry Price

3,898.00

Target Price

4,655.00

Duration

12-18 Month

BUY View Report
View More

Rapid Results

Divi's Laboratories Ltd. 23 May 2022 12:34 PM

Q4FY22 Quarterly Result Announced for Divi's Laboratories Ltd.

Pharmaceuticals firm Divi's Laboratories declares Q4FY22 result:

  • Divi's Labs earns a Revenue of Rs 9074 crores for FY22 on a consolidated basis.
  • Divi's Laboratories has earned a consolidated total revenue of Rs 9074 crores for the financial year 2021-22 as against Rs 7032 crores during the previous year, reflecting a growth of 29%.
  • PBT for the current year grew by 38% to Rs 3684 crores as against a PBT of Rs 2666 crores for the previous year.
  • PAT for the year amounted to Rs 2960 crores as against a PAT of Rs 1984 crores for the last year, reflecting a growth of 49%.

 

Result PDF

View More

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

View More

Equity

Reserves and Surplus

Debt

View More

Sales

Operating Profit

Profit after tax

View More

PE

Debt/Equity

P BV

View More

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 11,728.18 Cr FV: 2.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 2,384.58 23,141.09
LAST 3M 49,521.50 -18,551.54
LAST 6M 129,719.68 -157,153.27
LAST 12M 215,295.98 -222,611.80
  • Announcement
  • Corporate action

  • No Data Found

Date Action Type Ratio
Aug 11, 2022 Dividend 1500
Aug 17, 2021 Dividend 1000
Feb 25, 2020 Dividend 800
View More

Information

  • About Company
  • Company Info
  • Listing Info
35.05
51.94%
441.7918
34.96%
28.16%

Registered Address

1-72-23(P)/DIVIS/303 Divi Towe, Cyber Hills Gachibowli, Hyderabad, Telangana, 500032

Tel : 91-40-23786300/23786352/400
Email : mail:divislabs.com
Website : http://www.divislaboratories.com

Registrar

Karvy Computershare Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 532488
NSE Code : DIVISLAB
Book Closure Date (Month) : Aug
BSE Group : A
ISIN : INE361B01024

ICICIdirect Divis Laboratories Ltd FAQ

1. How can I buy Divis Laboratories Ltd share?
You can buy Divis Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Divis Laboratories Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 08, 2022 04:01 PM the closing price of Divis Laboratories Ltd was ₹ 3,938.65.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Aug 08, 2022 04:01 PM, the market cap of Divis Laboratories Ltd stood at ₹ 104,558.95.
The latest PE ratio of Divis Laboratories Ltd as of Aug 08, 2022 04:01 PM is 35.05
The latest PB ratio of Divis Laboratories Ltd as of Aug 08, 2022 04:01 PM is 0.11
The 52-week high of Divis Laboratories Ltd is ₹ 5,425.00 while the 52-week low is ₹ 3,365.10 .
According to analyst recommendations, Divis Laboratories Ltd has a “Buy” rating for the long term.

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE